FI912888A0 - 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning. - Google Patents

2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning.

Info

Publication number
FI912888A0
FI912888A0 FI912888A FI912888A FI912888A0 FI 912888 A0 FI912888 A0 FI 912888A0 FI 912888 A FI912888 A FI 912888A FI 912888 A FI912888 A FI 912888A FI 912888 A0 FI912888 A0 FI 912888A0
Authority
FI
Finland
Prior art keywords
aminoalkyl
arylalkyl
methyl
general formula
therapeutic
Prior art date
Application number
FI912888A
Other languages
English (en)
Other versions
FI912888A (fi
Inventor
Bernard Raizon
Yannick Evanno
Odette Legalloudec
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9007483A external-priority patent/FR2663330B1/fr
Priority claimed from FR9104578A external-priority patent/FR2675143B3/fr
Application filed by Synthelabo filed Critical Synthelabo
Publication of FI912888A0 publication Critical patent/FI912888A0/fi
Publication of FI912888A publication Critical patent/FI912888A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Medicinal Preparation (AREA)
FI912888A 1990-06-15 1991-06-14 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning. FI912888A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9007483A FR2663330B1 (fr) 1990-06-15 1990-06-15 0derives de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxanes, leur preparation et leur application en therapeutique.
FR9104578A FR2675143B3 (fr) 1991-04-15 1991-04-15 Derives de 2-(aminoalkyl)-5-naphtyl-1,3-dioxanes, leur preparation et leur application en therapeutique.

Publications (2)

Publication Number Publication Date
FI912888A0 true FI912888A0 (fi) 1991-06-14
FI912888A FI912888A (fi) 1991-12-16

Family

ID=26228078

Family Applications (1)

Application Number Title Priority Date Filing Date
FI912888A FI912888A (fi) 1990-06-15 1991-06-14 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning.

Country Status (20)

Country Link
US (1) US5192797A (fi)
EP (1) EP0461958B1 (fi)
JP (1) JPH0813808B2 (fi)
KR (1) KR920000744A (fi)
AT (1) ATE111460T1 (fi)
AU (1) AU643290B2 (fi)
CA (1) CA2044699A1 (fi)
CZ (1) CZ280084B6 (fi)
DE (1) DE69103968T2 (fi)
DK (1) DK0461958T3 (fi)
ES (1) ES2064057T3 (fi)
FI (1) FI912888A (fi)
HU (1) HU208432B (fi)
IE (1) IE65067B1 (fi)
IL (1) IL98454A (fi)
NO (1) NO177995C (fi)
NZ (1) NZ238557A (fi)
PL (1) PL164840B1 (fi)
PT (1) PT97991B (fi)
SK (1) SK278142B6 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2714058B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 1,3-dioxane trisubstitués, leur préparation et leur application en thérapeutique.
FR2714056B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 2-(aminoalkyl)-5-(arylalkyl)-1,3-dioxane, leur préparation et leur application en thérapeutique.
FR2714055B1 (fr) * 1993-12-22 1996-01-19 Synthelabo Dérivés de 5-(arylalkyl)-1,3-dioxane substitués en position 2, leur préparation et leur utilisation en thérapeutique.
FR2720939B1 (fr) 1994-06-08 1996-07-12 Synthelabo Utilisation de dérivés de N-[[5-(naphtalén-1-yl)-1,3-dioxan-2-yl]alkyl] acétamide pour la préparation de médicaments utiles dans le traitement des désordres neurodégénératifs.
FR2742152B1 (fr) * 1995-12-06 1998-01-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2764287B1 (fr) * 1997-06-05 1999-07-16 Synthelabo Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
KR20010013435A (ko) * 1997-06-05 2001-02-26 고든 라이트 5-나프탈렌-1-일-1,3-디옥산 유도체, 제조 및 치료에의 이용
FR2843964B1 (fr) * 2002-08-29 2004-10-01 Sanofi Synthelabo Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
EP1604654A1 (en) * 2004-05-18 2005-12-14 Schwarz Pharma Ag Novel use of peptide compounds for treating dyskinesia
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
WO2010003624A2 (en) 2008-07-09 2010-01-14 Sanofi-Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1554878A (fi) * 1967-12-12 1969-01-24
US4116670A (en) * 1977-04-04 1978-09-26 Velsicol Chemical Company Dioxane substituted amides
US4097491A (en) * 1977-06-10 1978-06-27 Velsicol Chemical Corporation N-Dialkoxyalkyl-N-dioxanalkylene-α-haloalkanamides

Also Published As

Publication number Publication date
US5192797A (en) 1993-03-09
DE69103968T2 (de) 1995-03-23
PT97991A (pt) 1992-03-31
IE65067B1 (en) 1995-10-04
IE912045A1 (en) 1991-12-18
ES2064057T3 (es) 1995-01-16
NO177995C (no) 1996-01-03
PL164840B1 (pl) 1994-10-31
SK278142B6 (en) 1996-02-07
NO177995B (no) 1995-09-25
EP0461958A1 (fr) 1991-12-18
NO912298L (no) 1991-12-16
CA2044699A1 (en) 1991-12-16
ATE111460T1 (de) 1994-09-15
AU643290B2 (en) 1993-11-11
HU911992D0 (en) 1991-12-30
PL290676A1 (en) 1991-12-16
CZ280084B6 (cs) 1995-10-18
DK0461958T3 (da) 1995-02-20
FI912888A (fi) 1991-12-16
AU7843391A (en) 1991-12-19
JPH04230277A (ja) 1992-08-19
IL98454A (en) 1996-07-23
IL98454A0 (en) 1992-07-15
PT97991B (pt) 1998-11-30
NZ238557A (en) 1992-04-28
HU208432B (en) 1993-10-28
HUT59124A (en) 1992-04-28
EP0461958B1 (fr) 1994-09-14
NO912298D0 (no) 1991-06-14
KR920000744A (ko) 1992-01-29
DE69103968D1 (de) 1994-10-20
CS183791A3 (en) 1992-01-15
JPH0813808B2 (ja) 1996-02-14

Similar Documents

Publication Publication Date Title
DK0842661T3 (da) Anvendelse af estrogenagonister og -antagonister til fremstilling af et lægemiddel til behandling af atherosclerose, uafhængigt af lipidsænkning
FI912888A (fi) 2-(aminoalkyl)-5-(arylalkyl)-1,3 -dioxanderivat, deras framstaellning och terapeutiska tillaempning.
IT1171879B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica
DK71780A (da) Fremgangsmaade til fremstilling af difenylhydantoinderivater
FI894134A0 (fi) Disubstituerade bensylaminer, deras framstaellningsprocess, deras anvaendning som medicin och deras framstaellningsaemnen.
DK0499544T3 (da) Anvendelse af tetrahydrothienopyridinderivater som inhibitorer af angiogenese
ES2127762T3 (es) Quinoleinas 2-sustituidas para el tratamiento de las leismaniosis.
ATE95816T1 (de) 2-((4-piperidinyl)methyl>-1,2,3,4tetrahydroisochinolin-derivate, ihre herstellung und ihre therapeutische verwendung.
ATE102199T1 (de) 4-amino-3-carboxynaphthyridin-derivate, ihre herstellung und pharmazeutische zusammensetzungen.
KR900009640A (ko) 벤족 사제핀 유도체
ES2118343T3 (es) Nuevos derivados de 2-(1h)-quinoleinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
SE8605458D0 (sv) 4-hydroxycoumarin derivatives
ATE76398T1 (de) 4-amino-1-trifluoromethyl-tetralin-derivate, deren herstellung und deren therapeutische verwendung.
ATE33134T1 (de) 2-aminoethyl-pyridin oder pyrazin-derivate, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0395527T3 (da) Imidazobenzodiazepiner og deres salte, fremgangsmåde til deres fremstilling, deres anvendelse som lægemidler og præparater med indhold deraf
FI942265A (fi) 2-aminopyratsin-5-karboksamidijohdannaiset, niiden valmistus ja terapeuttinen käyttö
ATE36536T1 (de) Phosphoroimidate.

Legal Events

Date Code Title Description
FA Application withdrawn